Paul Weiss, Cooley Drive $1.41B Deal For Portola Pharma
Alexion Pharmaceuticals has agreed to buy biotechnology firm Portola Pharmaceuticals for roughly $1.41 billion, the companies said Tuesday, in an agreement that stands to strengthen Alexion's ability to develop treatments for...To view the full article, register now.
Already a subscriber? Click here to view full article